SELLAS Life Sciences Group, Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
SELLAS Life Sciences Group, Inc. (SLS) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2017-11-09
- SELLAS Life Sciences Group, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2017-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2017-06-30 was -$0.03.
- SELLAS Life Sciences Group, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2016-09-30 was -$0.25.
- SELLAS Life Sciences Group, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2016-06-30 was -$0.32.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | -$0.31 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$0.03 10-Q · filed 2017-08-14 | -$0.34 10-Q · filed 2017-08-14 | |
| 2016-09-30 | -$0.25 10-Q · filed 2017-11-09 | -$0.93 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$0.32 10-Q · filed 2017-08-14 | -$0.17 10-Q · filed 2017-08-14 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | |
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-09 | -$0.03 10-Q · filed 2013-08-09 | |
| 2011-06-30 | -$0.06 10-Q · filed 2012-08-14 | -$0.14 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |